0

533212

GKB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GKB OPHTHALMICS LTD. Share Price Today

GKB OPHTHALMICS LTD. is currently trading at ₹63.44, up by ₹0.34 from the previous close. The stock touched an intraday high of ₹64.40 and a low of ₹61.15 during the latest trading session. Over the past one year, GKB OPHTHALMICS LTD. has delivered a loss of 17.68%, while the stock has declined 2.95% in the last one month.

Investment Returns

Over 1 Month -2.95% Over 3 Months -2.15% Over 6 Months 21.57% Over 1 Year -17.68%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GKB OPHTHALMICS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 32.00
  • P/E Ratio (TTM) -8.91
  • Beta 1.46
  • Book Value / share 28.41
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -1.88
info icon alternate text

GKB OPHTHALMICS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 6.40
Operating Expense 7.83
Net Profit -1.88
Net Profit Margin (%) -29.37
Earnings Per Share (EPS) -3.74
EBITDA -0.94
Effective Tax Rate (%) 2.07
Particulars DEC 2025 (Values in Cr)
Revenue 4.36
Operating Expense 6.69
Net Profit 0.98
Net Profit Margin (%) 22.47
Earnings Per Share (EPS) 1.95
EBITDA 2.19
Effective Tax Rate (%) -7.69
Particulars SEP 2025 (Values in Cr)
Revenue 6.11
Operating Expense 7.98
Net Profit -0.52
Net Profit Margin (%) -8.51
Earnings Per Share (EPS) -1.04
EBITDA 0.75
Effective Tax Rate (%) -4.00
Particulars JUN 2025 (Values in Cr)
Revenue 8.77
Operating Expense 10.96
Net Profit -2.14
Net Profit Margin (%) -24.40
Earnings Per Share (EPS) -4.25
EBITDA -0.77
Effective Tax Rate (%) -0.93
Particulars MAR 2025 (Values in Cr)
Revenue 8.43
Operating Expense 10.87
Net Profit -2.48
Net Profit Margin (%) -29.41
Earnings Per Share (EPS) -4.92
EBITDA -1.17
Effective Tax Rate (%) -1.63
Particulars MAR 2026 (Values in Cr)
Revenue 25.64
Operating Expense 33.47
Net Profit -3.57
Net Profit Margin (%) -13.92
Earnings Per Share (EPS) -7.08
EBITDA 1.21
Effective Tax Rate (%) 2.19
Particulars MAR 2025 (Values in Cr)
Revenue 32.75
Operating Expense 40.76
Net Profit -6.11
Net Profit Margin (%) -18.65
Earnings Per Share (EPS) -12.12
EBITDA -1.51
Effective Tax Rate (%) -1.15
Particulars MAR 2024 (Values in Cr)
Revenue 31.18
Operating Expense 36.63
Net Profit -3.42
Net Profit Margin (%) -10.96
Earnings Per Share (EPS) -6.78
EBITDA 0.80
Effective Tax Rate (%) -1.18
Particulars MAR 2023 (Values in Cr)
Revenue 27.73
Operating Expense 32.86
Net Profit -2.88
Net Profit Margin (%) -10.38
Earnings Per Share (EPS) -5.72
EBITDA 1.00
Effective Tax Rate (%) 5.26
Particulars MAR 2022 (Values in Cr)
Revenue 27.05
Operating Expense 31.32
Net Profit -2.31
Net Profit Margin (%) -8.53
Earnings Per Share (EPS) -4.58
EBITDA 1.52
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 103.24
ROE % -12.66
ROCE % -6.05
Total Debt to Total Equity 0.23
EBITDA Margin -1.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.58
ROE % -4.87
ROCE % -1.15
Total Debt to Total Equity 0.19
EBITDA Margin 2.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 124.38
ROE % 0.22
ROCE % 2.28
Total Debt to Total Equity 0.18
EBITDA Margin 6.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 125.17
ROE % 3.09
ROCE % 4.47
Total Debt to Total Equity 0.19
EBITDA Margin 8.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 124.30
ROE % 0.43
ROCE % 2.79
Total Debt to Total Equity 0.22
EBITDA Margin 9.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 35.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.70
EBITDA Margin -4.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.43
EBITDA Margin 2.57
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 3.61
Particulars MAR 2022 (Values in Cr)
Book Value / Share 60.32
ROE % -7.31
ROCE % -2.12
Total Debt to Total Equity 0.38
EBITDA Margin 5.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 65.01
ROE % -3.23
ROCE % 0.13
Total Debt to Total Equity 0.32
EBITDA Margin 14.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 13.82
Total Assets 125.21
Total Liabilities 125.21
Total Equity 56.43
Share Outstanding 0
Price to Book Ratio 1.72
Return on Assets (%) -5.62
Return on Capital (%) -9.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 17.83
Total Assets 114.50
Total Liabilities 114.50
Total Equity 64.20
Share Outstanding 0
Price to Book Ratio 1.83
Return on Assets (%) -2.45
Return on Capital (%) -3.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.45
Total Assets 112.08
Total Liabilities 112.08
Total Equity 67.29
Share Outstanding 0
Price to Book Ratio 1.99
Return on Assets (%) -0.14
Return on Capital (%) -0.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 16.39
Total Assets 110.15
Total Liabilities 110.15
Total Equity 67.41
Share Outstanding 0
Price to Book Ratio 1.53
Return on Assets (%) 1.15
Return on Capital (%) 1.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 17.28
Total Assets 106.81
Total Liabilities 106.81
Total Equity 66.30
Share Outstanding 0
Price to Book Ratio 1.26
Return on Assets (%) -0.84
Return on Capital (%) -1.16
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 49.48
Total Liabilities 49.48
Total Equity 17.67
Share Outstanding 0
Price to Book Ratio 1.72
Return on Assets (%) -12.34
Return on Capital (%) -17.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 48.39
Total Liabilities 48.39
Total Equity 23.98
Share Outstanding 0
Price to Book Ratio 1.83
Return on Assets (%) -7.05
Return on Capital (%) -9.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 49.14
Total Liabilities 49.14
Total Equity 27.51
Share Outstanding 0
Price to Book Ratio 1.99
Return on Assets (%) -5.86
Return on Capital (%) -7.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 53.89
Total Liabilities 53.89
Total Equity 30.40
Share Outstanding 0
Price to Book Ratio 1.53
Return on Assets (%) -4.28
Return on Capital (%) -5.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 56.86
Total Liabilities 56.86
Total Equity 32.77
Share Outstanding 0
Price to Book Ratio 1.26
Return on Assets (%) -3.70
Return on Capital (%) -4.71
Particulars MAR 2025 (Values in Cr)
Net Income -6.72
Cash from Operations -3.29
Cash from Investing 2.54
Cash from Financing 0.66
Net change in Cash -0.21
Free Cash Flow -1.14
Particulars MAR 2024 (Values in Cr)
Net Income -2.77
Cash from Operations 4.40
Cash from Investing -1.71
Cash from Financing -1.63
Net change in Cash 0.86
Free Cash Flow 6.48
Particulars MAR 2023 (Values in Cr)
Net Income 0.13
Cash from Operations -2.60
Cash from Investing 1.42
Cash from Financing -2.18
Net change in Cash -3.52
Free Cash Flow -1.39
Particulars MAR 2022 (Values in Cr)
Net Income 1.94
Cash from Operations 5.14
Cash from Investing -3.52
Cash from Financing -1.66
Net change in Cash -0.12
Free Cash Flow 9.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.92
Cash from Operations 6.89
Cash from Investing -16.77
Cash from Financing 2.76
Net change in Cash -7.15
Free Cash Flow 13.22
Particulars MAR 2025 (Values in Cr)
Net Income -6.03
Cash from Operations -5.00
Cash from Investing -0.15
Cash from Financing 5.12
Net change in Cash -0.07
Free Cash Flow -3.58
Particulars MAR 2024 (Values in Cr)
Net Income -3.37
Cash from Operations 1.37
Cash from Investing 0.37
Cash from Financing -1.73
Net change in Cash 0.00
Free Cash Flow 2.62
Particulars MAR 2023 (Values in Cr)
Net Income -3.03
Cash from Operations -1.10
Cash from Investing 2.39
Cash from Financing -2.02
Net change in Cash -0.77
Free Cash Flow -0.29
Particulars MAR 2022 (Values in Cr)
Net Income -2.30
Cash from Operations 2.33
Cash from Investing -0.83
Cash from Financing -1.49
Net change in Cash 0.00
Free Cash Flow 6.14
Particulars MAR 2021 (Values in Cr)
Net Income -2.28
Cash from Operations 2.11
Cash from Investing -11.52
Cash from Financing 0.61
Net change in Cash -8.80
Free Cash Flow 5.75
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
BRITANNIA INDUSTRIES LTD 5244.40 49.86 24.73 126320.97 5038.00 6336.95
NESTLE INDIA LTD. 1400.25 79.33 52.35 270012.21 1085.00 1498.60
FOODS & INNS LTD. 56.65 15.03 0.73 416.56 45.00 128.79
HINDUSTAN UNILEVER LTD. 2218.50 34.23 10.69 521256.82 2023.05 2734.31
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
BRITANNIA INDUSTRIES LTD 5244.40 49.31 27.21 126320.97 5038.00 6336.95
COLGATE PALMOLIVE LTD. 2026.60 41.02 34.79 55120.61 1781.60 2505.00
NESTLE INDIA LTD. 1400.25 78.31 50.85 270012.21 1085.00 1498.60
FOODS & INNS LTD. 56.65 13.30 0.72 416.56 45.00 128.79

GKB OPHTHALMICS LTD. shareholding pattern

Holding
47.08%
51.12%
1.78%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

GKB OPHTHALMICS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
63.44 0.53 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 63.20
  • 26 Days 63.90
  • 10 Days 63.30
  • 50 Days 63.80
  • 12 Days 63.40
  • 100 Days 62.70
  • 20 Days 63.80
  • 200 Days 64.70
62.87 PIVOT
First Support 61.73 First Resistance 64.23 Second Support 60.37 Second Resistance 65.37 Third Support 59.23 Third Resistance 66.73
RSI 47.99 ADX 32.24 MACD -0.60 Williams % R -47.81 Commodity Channel Index (CCI) -44.06
Date 2026-06-18 Week 1284.00 Same Day 685.00 Month 1449.00
1 Year 1.47 3 Year 1.05
Over 1 Month
-2.95% down
Over 1 Year
-17.68% down
Over 3 Months
-2.15% down
Over 3 Years
-10.86% down
Over 6 Months
21.57% down
Over 5 Years
-8.92% down

GKB OPHTHALMICS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2010 1.2 Final 23 Sep 2010 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of GKB Ophthalmics Ltd?

Answer Field

GKB Ophthalmics Ltd share price is for NSE ₹ 84.05 & for BSE ₹ 63.44 as on Jun 19 2026 12:36 PM.

What is the Market Cap of GKB Ophthalmics Ltd Share?

Answer Field

The market cap of GKB Ophthalmics Ltd for NSE ₹ 0.00 & for BSE ₹ 32.00 as on Jun 19 2026 12:36 PM.

What is the 52 Week High and Low of GKB Ophthalmics Ltd?

Answer Field

The 52 Week High and Low of GKB Ophthalmics Ltd for NSE is ₹ 90.90 and ₹ 0.00 and for BSE is ₹ 91.70 and ₹ 45.25.

What is 1 year return for GKB Ophthalmics Ltd?

Answer Field

The 1 year returns on the stock has been -17.68%.

What is the P/E Ratio of GKB Ophthalmics Ltd Share?

Answer Field

As on Jun 19 2026 12:36 PM the price-to-earnings (PE) ratio for GKB Ophthalmics Ltd share is -8.91.

What is the PB ratio of GKB Ophthalmics Ltd Share?

Answer Field

As on Jun 19 2026 12:36 PM, the price-to-book (PB) ratio for GKB Ophthalmics Ltd share is 28.41.

How to Buy GKB Ophthalmics Ltd Share?

Answer Field

You can trade in GKB Ophthalmics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy GKB Ophthalmics Ltd Share on Bajaj Broking App?

Answer Field

To buy GKB Ophthalmics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “GKB Ophthalmics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|